The Impact of Beta- and Gamma-synucleins on Alpha-synuclein's Synaptic Function
The Impact of Beta- and Gamma-synucleins on Alpha-synuclein's Synaptic Function
批准号:
10830522
负责人:
Jacqueline Burre
金额:
$3.66万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-05-01 至 2024-03-31
关键词:
AffectAgeAlzheimer&aposs disease related dementiaAmyotrophic Lateral SclerosisAnimalsAreaBasic ScienceBindingBiochemicalBiophysicsBrainCellsComplexDementiaDevelopmentDiseaseElectrophysiology (science)ExocytosisFosteringFunctional disorderGamma synucleinGaucher DiseaseHippocampusKnockout MiceLewy Body DementiaLinkMedicalMissionModelingMolecularMolecular ChaperonesMusNeurodegenerative DisordersNeuronsParkinson DiseasePathologicPathologyPhysiologicalPlayPublic HealthRecombinant ProteinsResearchRoleSNAP receptorSliceSynapsesSynaptic VesiclesTestingTherapeutic InterventionTranslational ResearchUnited States National Institutes of HealthVAMP-2Workalpha synucleininnovationinsightinterdisciplinary approachmouse modelnervous system disorderneurotransmitter releasenovelnovel therapeutic interventionphosphoneuroprotein 14preventsynaptic functionsynucleinsynucleinopathyvirtual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
αSynuclein (αSyn) plays an important role at the synapse, to maintain neurotransmitter release via clustering
synaptic vesicles (SV) and chaperoning SNARE-complex assembly. Aggregation of αSyn is a key pathological
feature in multiple age-driven neurodegenerative diseases such as Parkinson’s disease (PD) and Alzheimer’s
disease related dementias (ADRD) such as Lewy body dementia. Despite the involvement of βSyn and γSyn in
synucleinopathies including Lewy body dementia, Gaucher’s disease, and PD, virtually nothing is known about
their physiological functions in the brain. Understanding their function is the first step to finding out how their
dysfunction causes PD and Alzheimer’s disease related dementias including Lewy body dementia, and how
these diseases can be prevented or delayed. The objective here is to determine the effects of βSyn and γSyn
on αSyn’s synaptic function. The central hypothesis is that interaction of βSyn and γSyn with αSyn causes a
reduction in αSyn’s activity, leading to reduced SV clusters and SNARE-complex assembly, and altered neu-
ronal activity. This hypothesis will be tested in 3 specific aims: 1) Assess the effect of βSyn and γSyn on
SNARE-complex assembly; 2) Assess the effect of βSyn and γSyn on SV clustering; and 3) Determine the im-
plications of synuclein interactions on SV cycling. Under aim 1, SNARE-complex assembly will be quantified in
select brain areas and neurons from mice lacking βSyn and/or γSyn, in heterologous cells and using recombi-
nant proteins. Under aim 2, synaptobrevin-2 binding and multimerization of αSyn, and SV pools will be quanti-
fied in mice lacking βSyn and/or γSyn and using recombinant proteins. Under aim 3, SV exocytosis and cycling
will be quantified in hippocampal brain slices and in neurons from mice lacking βSyn and/or γSyn with or with-
out lentivirally increasing βSyn or γSyn levels. This research is innovative because it (1) tests the novel hypoth-
esis that βSyn and γSyn affect the synaptic function of αSyn, (2) uses a multidisciplinary approach combining
biophysical, biochemical, electrophysiological and whole animal approaches, and (3) analyzes new mouse
models lacking βSyn and/or γSyn that were generated from αβγSyn triple knockout mice, that not only enable
a direct comparison of the synucleins but may serve as models for synucleinopathies and Alzheimer’s disease
related dementias including Lewy body dementia. Our work is significant because it (1) will clarify the im-
portance of βSyn and γSyn for neuronal function, (2) will provide new insights into the molecular mechanism
underlying SV binding of αSyn, (3) may uncover the contributions of βSyn and γSyn to synucleinopathies and
Alzheimer’s disease related dementias including Lewy body dementia, and (4) has translational importance for
the targeted development of new treatment strategies for the above-mentioned age-driven dementias aimed at
targeting all synucleins instead of focusing solely on αSyn. With synuclein pathology and co-pathologies com-
mon to PD and Alzheimer’s disease related dementias including Lewy body dementia, our study has the poten-
tial to contribute a mechanistic understanding of the role of the three synucleins in these synucleinopathies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Synaptic vesicle changes in synucleinopathies
-
批准号:10500910
-
项目类别:
-
资助金额:$46.4万
-
财政年份:2022
-
负责人:Jacqueline Burre
-
依托单位:
Changes in synaptic vesicle-binding of alpha-synuclein in the central and enteric nervous system
-
批准号:10527040
-
项目类别:
-
资助金额:$6.44万
-
财政年份:2022
-
负责人:Jacqueline Burre
-
依托单位:
The impact of beta- and gamma-synucleins on alpha-synuclein's synaptic function
-
批准号:10416674
-
项目类别:
-
资助金额:$230.57万
-
财政年份:2022
-
负责人:Jacqueline Burre
-
依托单位:
The role of VAMP2 in alpha-synuclein function and pathology
-
批准号:10386861
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2021
-
负责人:Jacqueline Burre
-
依托单位:
The role of VAMP2 in alpha-synuclein function and pathology
-
批准号:10474868
-
项目类别:
-
资助金额:$4.1万
-
财政年份:2021
-
负责人:Jacqueline Burre
-
依托单位:
The role of VAMP2 in alpha-synuclein function and pathology
-
批准号:10599847
-
项目类别:
-
资助金额:$37.56万
-
财政年份:2021
-
负责人:Jacqueline Burre
-
依托单位:
The role of VAMP2 in alpha-synuclein function and pathology
-
批准号:10179561
-
项目类别:
-
资助金额:$39.05万
-
财政年份:2021
-
负责人:Jacqueline Burre
-
依托单位:
The impact of synaptic vesicle-binding of alpha-synuclein on neuron function and neuropathology
-
批准号:10665732
-
项目类别:
-
资助金额:$43.9万
-
财政年份:2020
-
负责人:Jacqueline Burre
-
依托单位:
The impact of synaptic vesicle-binding of alpha-synuclein on neuron function and neuropathology
-
批准号:10175072
-
项目类别:
-
资助金额:$51.16万
-
财政年份:2020
-
负责人:Jacqueline Burre
-
依托单位:
The impact of synaptic vesicle-binding of alpha-synuclein on neuron function and neuropathology
-
批准号:10406166
-
项目类别:
-
资助金额:$51.26万
-
财政年份:2020
-
负责人:Jacqueline Burre
-
依托单位:
Molecular mechanisms of Munc18-1 linked infantile seizure disorders and rational rescue strategies
-
批准号:9360727
-
项目类别:
-
资助金额:$35.92万
-
财政年份:2017
-
负责人:Jacqueline Burre
-
依托单位:
Molecular mechanisms of Munc18-1 linked infantile seizure disorders and rational rescue strategies
-
批准号:10117291
-
项目类别:
-
资助金额:$36.65万
-
财政年份:2017
-
负责人:Jacqueline Burre
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: